Bayer expects around 3% cost for Merck acquisition debt

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Bayer expects around 3% cost for Merck acquisition debt

Bayer scientist  230x150

German chemical and pharmaceutical company Bayer has mandated three banks for a bridge loan to finance its $14.2bn acquisition of Merck & Co's consumer care business.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • 4 capital markets databases
  • Daily newsletters across markets and asset classes
  • 2 weekly podcasts
Gift this article